Viking Therapeutics (VKTX) announced the completion of subject enrollment in its Phase 2 clinical trial of the oral tablet formulation of ...
Investor's Business Daily on MSN9h
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill StudyViking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback